hace 24 horas
Multicancer blood test screening: no reduction in stage III to IV cancer incidence
In the NHS-Galleri randomized trial of 142,250 adults aged 50 to 77 years, three annual screening rounds did not change stage III or IV cancers overall, with a borderline lower stage IV rate and less than 1% nonserious adverse events.
Randomized Controlled Trial
NEJM